OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1α and inhibiting the RhoA/ROCK pathway
Na Li, Qiuxiao Zhu, Guizhi Li, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 12, pp. 1862-1876
Open Access | Times Cited: 8
Na Li, Qiuxiao Zhu, Guizhi Li, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 12, pp. 1862-1876
Open Access | Times Cited: 8
Showing 8 citing articles:
Empagliflozin Alleviates Carfilzomib-Induced Cardiotoxicity in Mice by Modulating Oxidative Stress, Inflammatory Response, Endoplasmic Reticulum Stress, and Autophagy
Mina Y. George, Mohamed S. Dabour, Eman Rashad, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 671-671
Open Access | Times Cited: 6
Mina Y. George, Mohamed S. Dabour, Eman Rashad, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 671-671
Open Access | Times Cited: 6
SGLT2 inhibitors: how do they affect the cardiac cells
Betül Rabia Erdoğan, Ebru Arioglu‐Inan
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 6
Betül Rabia Erdoğan, Ebru Arioglu‐Inan
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 6
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
Elina Khattab, Michaelia Kyriakou, Elena Leonidou, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 134-134
Open Access
Elina Khattab, Michaelia Kyriakou, Elena Leonidou, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 134-134
Open Access
The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights
Maja Muric, Ivan Srejović, Jovana Novaković, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Maja Muric, Ivan Srejović, Jovana Novaković, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Right ventricular dysfunction following surgical repair of tetralogy of Fallot: Molecular pathways and therapeutic prospects
Pingyi Fan, Yabo Wang, Qi An, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117924-117924
Closed Access
Pingyi Fan, Yabo Wang, Qi An, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117924-117924
Closed Access
The Off-Target Cardioprotective Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors: An Overview
Loredana N. Ionică, Adina V. Lința, Alina D. Bătrîn, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7711-7711
Open Access | Times Cited: 2
Loredana N. Ionică, Adina V. Lința, Alina D. Bătrîn, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7711-7711
Open Access | Times Cited: 2
Elucidating the cardioprotective mechanisms of sodium-glucose cotransporter-2 inhibitors beyond glycemic control
Kexin Zhang, Chengxia Kan, Fang Han, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 2, pp. 137-141
Open Access
Kexin Zhang, Chengxia Kan, Fang Han, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 2, pp. 137-141
Open Access
Mechanistic Insights and Therapeutic Potential of Astilbin and Apigenin in Diabetic cardiomyopathy
Sachin Dhiman, Sanchit Dhankhar, Anjali Garg, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39996-e39996
Open Access
Sachin Dhiman, Sanchit Dhankhar, Anjali Garg, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39996-e39996
Open Access
